{"id":"carbimazole","rwe":[{"pmid":"41894843","year":"2026","title":"Severe agranulocytosis in patient with Graves' disease on second exposure to carbimazole.","finding":"","journal":"Endocrinology, diabetes & metabolism case reports","studyType":"Clinical Study"},{"pmid":"41883708","year":"2026","title":"Diagnostic and Therapeutic Challenges in Seronegative Autoimmune Hepatitis With Concurrent Graves Disease and Immune Thrombocytopenia.","finding":"","journal":"ACG case reports journal","studyType":"Clinical Study"},{"pmid":"41867389","year":"2026","title":"Propylthiouracil Induced Neutropenia in Thyroid Storm: A Case Requiring Urgent Total Thyroidectomy.","finding":"","journal":"International medical case reports journal","studyType":"Clinical Study"},{"pmid":"41835682","year":"2026","title":"Thyroid Storm With Multiorgan Dysfunction Mimicking Sepsis: Thionamide-Sparing Bridge to Delayed Carbimazole.","finding":"","journal":"Cureus","studyType":"Clinical Study"},{"pmid":"41759496","year":"2026","title":"Autoimmune hyperthyroidism following haematopoietic stem cell transplant for multiple sclerosis in an adult female: a case report and literature review.","finding":"","journal":"Endocrinology, diabetes & metabolism case reports","studyType":"Clinical Study"}],"tags":[{"label":"carbimazole","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Lactoperoxidase","category":"target"},{"label":"LPO","category":"gene"},{"label":"TPO","category":"gene"},{"label":"H03BB01","category":"atc"},{"label":"Active","category":"status"},{"label":"Graves' disease","category":"indication"},{"label":"Hyperthyroidism","category":"indication"},{"label":"Antithyroid Agents","category":"pharmacology"},{"label":"Hormone Antagonists","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":166.178,"date":"","count":58,"signal":"Hyperthyroidism","source":"DrugCentral FAERS","actionTaken":"Reported 58 times (LLR=166)"},{"llr":96.975,"date":"","count":99,"signal":"General physical health deterioration","source":"DrugCentral FAERS","actionTaken":"Reported 99 times (LLR=97)"},{"llr":75.566,"date":"","count":40,"signal":"Toxic epidermal necrolysis","source":"DrugCentral FAERS","actionTaken":"Reported 40 times (LLR=76)"},{"llr":63.17,"date":"","count":37,"signal":"Restlessness","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=63)"},{"llr":57.998,"date":"","count":22,"signal":"Dermatitis exfoliative","source":"DrugCentral FAERS","actionTaken":"Reported 22 times (LLR=58)"},{"llr":57.169,"date":"","count":37,"signal":"Hypothyroidism","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=57)"},{"llr":56.542,"date":"","count":19,"signal":"Fluid intake reduced","source":"DrugCentral FAERS","actionTaken":"Reported 19 times (LLR=57)"},{"llr":56.086,"date":"","count":27,"signal":"Cholecystitis","source":"DrugCentral FAERS","actionTaken":"Reported 27 times (LLR=56)"},{"llr":53.155,"date":"","count":9,"signal":"Diffuse vasculitis","source":"DrugCentral FAERS","actionTaken":"Reported 9 times (LLR=53)"},{"llr":50.614,"date":"","count":19,"signal":"Autoimmune haemolytic anaemia","source":"DrugCentral FAERS","actionTaken":"Reported 19 times (LLR=51)"},{"llr":49.472,"date":"","count":96,"signal":"Acute kidney injury","source":"DrugCentral FAERS","actionTaken":"Reported 96 times (LLR=49)"},{"llr":48.501,"date":"","count":30,"signal":"Agranulocytosis","source":"DrugCentral FAERS","actionTaken":"Reported 30 times (LLR=49)"},{"llr":44.171,"date":"","count":25,"signal":"Electrolyte imbalance","source":"DrugCentral FAERS","actionTaken":"Reported 25 times (LLR=44)"},{"llr":43.006,"date":"","count":28,"signal":"Hepatocellular injury","source":"DrugCentral FAERS","actionTaken":"Reported 28 times (LLR=43)"},{"llr":42.308,"date":"","count":30,"signal":"Respiratory disorder","source":"DrugCentral FAERS","actionTaken":"Reported 30 times (LLR=42)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CARBIMAZOLE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:07:31.211837+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:07:38.903153+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CARBIMAZOLE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:07:39.283163+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Thyroid peroxidase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:07:40.332932+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL508102/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:07:39.986186+00:00"}},"allNames":"carbimazol","offLabel":[],"synonyms":["carbimazole","athyromazole","carbethoxymethimazole","carbimazol","neomercazole"],"timeline":[{"date":"1959-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"brandName":"Carbimazol","ecosystem":[{"indication":"Graves' disease","otherDrugs":[],"globalPrevalence":null},{"indication":"Hyperthyroidism","otherDrugs":[{"name":"propylthiouracil","slug":"propylthiouracil","company":"Dava Pharms Inc"},{"name":"sodium iodide (131I)","slug":"sodium-iodide-(131i)","company":"Bracco"},{"name":"thiamazole","slug":"thiamazole","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Lactoperoxidase","targets":[{"gene":"LPO","source":"DrugCentral","target":"Lactoperoxidase","protein":"Lactoperoxidase"},{"gene":"TPO","source":"DrugCentral","target":"Thyroid peroxidase","protein":"Thyroid peroxidase"}],"modality":"Small Molecule","drugClass":"carbimazole","explanation":"","oneSentence":"","technicalDetail":"Carbimazol is a prodrug that is converted to its active metabolite, methimazole, which then inhibits the enzyme thyroid peroxidase (TPO), a key enzyme in the synthesis of thyroid hormones."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/497","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CARBIMAZOLE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CARBIMAZOLE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:14:31.610209","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:07:41.690658+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"thiamazole","drugSlug":"thiamazole","fdaApproval":"1950-06-21","relationship":"same-class"}],"genericName":"carbimazole","indications":{"approved":[{"name":"Graves' disease","source":"DrugCentral","snomedId":353295004,"regulator":"FDA"},{"name":"Hyperthyroidism","source":"DrugCentral","snomedId":34486009,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"thiamazole","brandName":"thiamazole","genericName":"thiamazole","approvalYear":"1950","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06864351","phase":"NA","title":"Prospective Evaluation of OptiThyDose","status":"RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2025-08-28","conditions":["Thyroid Diseases","Congenital Hypothyroidism","Graves Disease"],"enrollment":150,"completionDate":"2029-02"},{"nctId":"NCT03064542","phase":"","title":"The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure","status":"COMPLETED","sponsor":"Singapore Institute of Food and Biotechnology Innovation","startDate":"2015-10-13","conditions":["Hyperthyroidism"],"enrollment":30,"completionDate":"2023-05-19"},{"nctId":"NCT05512715","phase":"PHASE4","title":"LIthium as Bridging thErapy Prior to Radioactiveiodine in hyperThYroidism","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2021-01-10","conditions":["Hyperthyroidism/Thyrotoxicosis"],"enrollment":90,"completionDate":"2021-05-31"},{"nctId":"NCT05385029","phase":"","title":"Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19","status":"COMPLETED","sponsor":"OMER B ABDELBASIT","startDate":"2020-05-01","conditions":["Thyroid Dysfunction","Hypothyroidism","Hyperthyroidism"],"enrollment":95,"completionDate":"2021-09-30"},{"nctId":"NCT03303053","phase":"PHASE3","title":"Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism","status":"UNKNOWN","sponsor":"Clinical Research Centre, Malaysia","startDate":"2017-05-11","conditions":["Hyperthyroidism","Graves Disease"],"enrollment":135,"completionDate":"2018-03-01"},{"nctId":"NCT01436994","phase":"PHASE3","title":"Antithyroid Drug Treatment of Thyrotoxicosis in Young People","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2004-07","conditions":["Paediatric Thyrotoxicosis"],"enrollment":81,"completionDate":"2015-11"},{"nctId":"NCT00430547","phase":"NA","title":"Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies","status":"COMPLETED","sponsor":"Barwon Health","startDate":"2003-08","conditions":["Graves' Ophthalmopathy"],"enrollment":60,"completionDate":"2006-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000167064","NDDF":"002140","UNII":"8KQ660G60G","CHEBI":"CHEBI:617099","INN_ID":"323","RXNORM":"2020","UMLSCUI":"C0006983","chemblId":"CHEMBL508102","ChEMBL_ID":"CHEMBL508102","KEGG_DRUG":"D07616","DRUGBANK_ID":"DB00389","PUBCHEM_CID":"31072","SNOMEDCT_US":"325325006","MESH_DESCRIPTOR_UI":"D002231"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"0%"},"publicationCount":1116,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"H03BB01","allCodes":["H03BB01"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Jan 1","pmid":"41894843","title":"Severe agranulocytosis in patient with Graves' disease on second exposure to carbimazole.","journal":"Endocrinology, diabetes & metabolism case reports"},{"date":"2026 Mar","pmid":"41883708","title":"Diagnostic and Therapeutic Challenges in Seronegative Autoimmune Hepatitis With Concurrent Graves Disease and Immune Thrombocytopenia.","journal":"ACG case reports journal"},{"date":"2026","pmid":"41867389","title":"Propylthiouracil Induced Neutropenia in Thyroid Storm: A Case Requiring Urgent Total Thyroidectomy.","journal":"International medical case reports journal"},{"date":"2026 Feb","pmid":"41835682","title":"Thyroid Storm With Multiorgan Dysfunction Mimicking Sepsis: Thionamide-Sparing Bridge to Delayed Carbimazole.","journal":"Cureus"},{"date":"2026 Jan 1","pmid":"41759496","title":"Autoimmune hyperthyroidism following haematopoietic stem cell transplant for multiple sclerosis in an adult female: a case report and literature review.","journal":"Endocrinology, diabetes & metabolism case reports"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:07:41.690658+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}